AstraZeneca gets U.S. subpoena over UK d

April 28 [Sun], 2013, 16:57
LONDON (Reuters) - AstraZeneca said on Thursday it had received a subpoena from the U.S. Attorney's Office in Boston, Massachusetts, related to manufacturing standards at its Macclesfield facility in the north of England.

Britain's second biggest drugmaker said the approach was made on March 28 and the company was coordinating its response and intended to cooperate with the inquiry.

Chief Financial Officer Simon Lowth declined to go into further details about the case during a conference call with reporters following first-quarter results.

"It's a very early approach," he said.

The Macclesfield facility is AstraZeneca's second largest manufacturing site and its European center for packing medicines. More than 800 people work at the site on the manufacturing, packing and distribution of drugs for 130 global markets.

The facility includes a unique production line for making Zoladex, used to treat hormone-sensitive cancers of the prostate and breast, according to AstraZeneca's website.

(Reporting by Ben Hirschler. Editing by Jane Merriman)
  • URL:
小文字 太字 斜体 下線 取り消し線 左寄せ 中央揃え 右寄せ テキストカラー 絵文字 プレビューON/OFF


「ヤプログ!利用規約 第9条 禁止事項」に該当するコメントは禁止します。